Peter Friberg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Peter Friberg has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Walter Osika
Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden
4 shared publications - Yun Chen
School of Public Health and Community Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
4 shared publications - Katarina Laundy Frisenstam
School of Public Health and Community Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
3 shared publications - Anders K. Nilsson
Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
1 shared publication - Anders Lindahl
University of Gothenburg
1 shared publication - Anna Mia Ekström
Karolinska Institutet
1 shared publication
Latest Publications
- Open Access
- 13 February 2025
- Published by Springer Nature in Mindfulness
- Vol. 16 (2) , 569
Correction: Mindfulness-Based Intervention for Children with Mental Health Problems: A 2-Year Follow-up Randomized Controlled Study
- 13 February 2025
- Published by Springer Nature in Mindfulness
- Vol. 16 (2) , 569
Open AccessCorrection: Mindfulness-Based Intervention for Children with Mental Health Problems: A 2-Year Follow-up Randomized Controlled Study
- Open Access
- 16 October 2021
- Published by Springer Nature in Mindfulness
- Vol. 12 (12) , 3073-3085
Mindfulness-Based Intervention for Children with Mental Health Problems: a 2-Year Follow-up Randomized Controlled Study
Objectives: Moderate mental health problems are highly prevalent and increasing in Swedish schoolchildren, elevating risk for future mental and somatic disability. The aim of this study was to determine whether an 8-week mindfulness-based intervention, Training for Mindfulness and Resilience (TMR), mitigates mental health symptoms and increases resilience during a 2-year follow-up. Methods: Schoolchildren (aged 9–14 years) reporting moderate mental health problems were randomized into either TMR intervention group (N = 22) or control group, receiving best current practice (N = 12). We used validated questionnaires to measure anxiety, depression, anger, disruptive behavior, self-concept, resilience, stress, and mindfulness before treatment with either TMR or control, as well as at 6 months, 1 year, and 2 years follow-up. Results: We found a statistically significant effect of TMR intervention vs control, on resilience, anxiety, anger, and disruptive behavior. Compared to baseline, TMR increased the level of resilience at 6 months (p < .001); decreased anxiety at 1 (p < = .033) and 2 years (p = .04); anger at 6 months (p = .004) and 2 years (p = .039); disruptive behavior at 6 months (p = .006). In the control group, a decrease in resilience between 6 months and 2 years (p = .05) was observed. No other significant effects were found in the control group. Conclusions: This study suggested that TMR improved mental health in schoolchildren with effects on anxiety and anger lasting for 2 years, and on resilience and disruptive behavior lasting for 6 months. Trial Registration Number: NCT04806542, date of registration 18th of March 2021, retrospectively registered.
- 16 October 2021
- Published by Springer Nature in Mindfulness
- Vol. 12 (12) , 3073-3085
Open AccessMindfulness-Based Intervention for Children with Mental Health Problems: a 2-Year Follow-up Randomized Controlled Study
Objectives: Moderate mental health problems are highly prevalent and increasing in Swedish schoolchildren, elevating risk for future mental and somatic disability. The aim of this study was to determine whether an 8-week mindfulness-based intervention, Training for Mindfulness and Resilience (TMR), mitigates mental health symptoms and increases resilience during a 2-year follow-up. Methods: Schoolchildren (aged 9–14 years) reporting moderate mental health problems were randomized into either TMR intervention group (N = 22) or control group, receiving best current practice (N = 12). We used validated questionnaires to measure anxiety, depression, anger, disruptive behavior, self-concept, resilience, stress, and mindfulness before treatment with either TMR or control, as well as at 6 months, 1 year, and 2 years follow-up. Results: We found a statistically significant effect of TMR intervention vs control, on resilience, anxiety, anger, and disruptive behavior. Compared to baseline, TMR increased the level of resilience at 6 months (p < .001); decreased anxiety at 1 (p < = .033) and 2 years (p = .04); anger at 6 months (p = .004) and 2 years (p = .039); disruptive behavior at 6 months (p = .006). In the control group, a decrease in resilience between 6 months and 2 years (p = .05) was observed. No other significant effects were found in the control group. Conclusions: This study suggested that TMR improved mental health in schoolchildren with effects on anxiety and anger lasting for 2 years, and on resilience and disruptive behavior lasting for 6 months. Trial Registration Number: NCT04806542, date of registration 18th of March 2021, retrospectively registered.
- Open Access
- 11 March 2021
- Published by Springer Nature in Nature Medicine
- Vol. 27 (5) , 739-740
The battle for COVID-19 vaccines highlights the need for a new global governance mechanism
- 11 March 2021
- Published by Springer Nature in Nature Medicine
- Vol. 27 (5) , 739-740
Open AccessThe battle for COVID-19 vaccines highlights the need for a new global governance mechanism
- Open Access
- 7 March 2017
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 3 (1) , e9
Self-Reported Psychosomatic Complaints In Swedish Children, Adolescents, and Young Adults Living in Rural and Urban Areas: An Internet-Based Survey
A multidisciplinary journal that focuses on public health and technology, public health informatics, mass media campaigns, surveillance, and innovation in public health practice and research. Also dedicated to rapid open data sharing during epidemics.
- 7 March 2017
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 3 (1) , e9
Open AccessSelf-Reported Psychosomatic Complaints In Swedish Children, Adolescents, and Young Adults Living in Rural and Urban Areas: An Internet-Based Survey
A multidisciplinary journal that focuses on public health and technology, public health informatics, mass media campaigns, surveillance, and innovation in public health practice and research. Also dedicated to rapid open data sharing during epidemics.
- 1 September 2012
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 30 (Supplement) , e35
113 SELF-PERCEIVED PSYCHOSOMATIC HEALTH IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS
- 1 September 2012
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 30 (Supplement) , e35
113 SELF-PERCEIVED PSYCHOSOMATIC HEALTH IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS
- 1 September 2000
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 279 (3) , R1050-R1060
IGF-I treatment attenuates renal abnormalities induced by neonatal ACE inhibition
An intact renin-angiotensin system (RAS) during nephrogenesis is essential for normal renal development. We have shown previously that neonatal inhibition of the RAS, either with ANG II type 1-receptor blockade or angiotensin-converting enzyme (ACE) inhibition, induces irreversible renal abnormalities. The aim of the present study was to investigate whether an interrupted RAS can be compensated for by exogenous administration of another important renal growth-promoting factor, the insulin-like growth factor-I (IGF-I). Rats were treated daily with either the ACE inhibitor enalapril (10 mg/kg), recombinant human IGF-I (3 mg/kg), or the combination enalapril + IGF-I from perinatalday 3 to 13. Urinary concentrating ability, renal function, and renal morphology were assessed at adult age. The gene expression and localization of IGF-I, its receptor, and the growth hormone receptor (GHR) were investigated during ongoing ACE inhibition. The present study demonstrates normalized renal function and histology in enalapril + IGF-I-treated animals. Ongoing ACE inhibition suppressed the medullary IGF-I mRNA expression and altered the local distribution of both IGF-I and GHR. Thus the present study provides evidence for an interaction between the RAS and GH/IGF-I axis in renal development.
- 1 September 2000
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 279 (3) , R1050-R1060
IGF-I treatment attenuates renal abnormalities induced by neonatal ACE inhibition
An intact renin-angiotensin system (RAS) during nephrogenesis is essential for normal renal development. We have shown previously that neonatal inhibition of the RAS, either with ANG II type 1-receptor blockade or angiotensin-converting enzyme (ACE) inhibition, induces irreversible renal abnormalities. The aim of the present study was to investigate whether an interrupted RAS can be compensated for by exogenous administration of another important renal growth-promoting factor, the insulin-like growth factor-I (IGF-I). Rats were treated daily with either the ACE inhibitor enalapril (10 mg/kg), recombinant human IGF-I (3 mg/kg), or the combination enalapril + IGF-I from perinatalday 3 to 13. Urinary concentrating ability, renal function, and renal morphology were assessed at adult age. The gene expression and localization of IGF-I, its receptor, and the growth hormone receptor (GHR) were investigated during ongoing ACE inhibition. The present study demonstrates normalized renal function and histology in enalapril + IGF-I-treated animals. Ongoing ACE inhibition suppressed the medullary IGF-I mRNA expression and altered the local distribution of both IGF-I and GHR. Thus the present study provides evidence for an interaction between the RAS and GH/IGF-I axis in renal development.
- 1 February 1998
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 25 (2) , 88-91
ANGIOTENSIN-CONVERTING ENZYME INHIBITION IN PIGLETS INDUCES PERSISTENT RENAL ABNORMALITIES
1. We have previously shown that neonatal angiotensin‐converting enzyme (ACE) inhibition or angiotensin II type I (AT1) receptor antagonism during the first three postnatal weeks in the rat produces persistent abnormalities in renal function and histology, indicating an essential role for the reninangiotensin system (RAS) in normal renal development. 2. The aim of the present study was to investigate whether the pig kidney, which shows a high resemblance to the human kidney, is dependent on an intact RAS neonatally for normal renal development, analogous with findings in rats. 3. Piglets received daily i.p. injections of either enalapril (10 mg/kg) or vehicle from 2 to 24 days after birth. Urine concentrating capacity, renal functional parameters and renal histology were assessed in 8‐week‐old pigs. 4. Urine osmolality after 20 h water deprivation was 673 ± 55 and 928 ± 50 mOsm/kg (P < 0.05) in enalapril‐ and vehicle‐treated pigs, respectively. There were no significant differences between groups in plasma creatinine or urea concentrations. 5. Semiquantitative analysis of renal histology showed significant interstitial fibrosis and inflammation, tubular atrophy and thickened walls of interlobular arteries in enalapril‐treated pigs. 6. The present study demonstrates that an intact RAS is required for normal renal development in the pig, similar to previous observations made in rodents.
- 1 February 1998
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 25 (2) , 88-91
ANGIOTENSIN-CONVERTING ENZYME INHIBITION IN PIGLETS INDUCES PERSISTENT RENAL ABNORMALITIES
1. We have previously shown that neonatal angiotensin‐converting enzyme (ACE) inhibition or angiotensin II type I (AT1) receptor antagonism during the first three postnatal weeks in the rat produces persistent abnormalities in renal function and histology, indicating an essential role for the reninangiotensin system (RAS) in normal renal development. 2. The aim of the present study was to investigate whether the pig kidney, which shows a high resemblance to the human kidney, is dependent on an intact RAS neonatally for normal renal development, analogous with findings in rats. 3. Piglets received daily i.p. injections of either enalapril (10 mg/kg) or vehicle from 2 to 24 days after birth. Urine concentrating capacity, renal functional parameters and renal histology were assessed in 8‐week‐old pigs. 4. Urine osmolality after 20 h water deprivation was 673 ± 55 and 928 ± 50 mOsm/kg (P < 0.05) in enalapril‐ and vehicle‐treated pigs, respectively. There were no significant differences between groups in plasma creatinine or urea concentrations. 5. Semiquantitative analysis of renal histology showed significant interstitial fibrosis and inflammation, tubular atrophy and thickened walls of interlobular arteries in enalapril‐treated pigs. 6. The present study demonstrates that an intact RAS is required for normal renal development in the pig, similar to previous observations made in rodents.